{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:50:37Z","timestamp":1768560637615,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ijrobp.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T21:29:21Z","timestamp":1683840561000},"page":"664-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer\/Lymphoma Study Association\/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned"],"prefix":"10.1016","volume":"117","author":[{"given":"Berthe M.P.","family":"Aleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.M.","family":"van der Maazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Meijnders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Beijert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Boros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Izar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile P.M.","family":"Janus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Levis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coreen","family":"Corning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Clementel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Raemaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc P.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Fortpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Girinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.05.011_bib0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrclinonc.2012.91","article-title":"State of the art in the treatment of Hodgkin lymphoma","volume":"9","author":"Borchmann","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2016.05.008","article-title":"Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance","volume":"53","author":"Ng","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0003","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin's lymphoma: An analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0004","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2013.51.9298","article-title":"Omitting radiotherapy in early positron emission tomography-negative stage I\/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"32","author":"Raemaekers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0005","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: Final results of the randomized EORTC\/LYSA\/FIL H10 Trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0006","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0007","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(20)30601-X","article-title":"PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): A multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Borchmann","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0009","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease","volume":"357","author":"Ferm\u00e9","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0011","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hon.166_2631","article-title":"Preliminary results of a quality control study on involved node radiotherapy in the EORTC\/LYSA\/FIL H10 trial on stages I\/II Hodgkin lymphoma","volume":"37","author":"Aleman","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0012","series-title":"International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU report 50","year":"1993"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0013","unstructured":"ICRU, International Commission on Radiation Units and Measurements.Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU 50), ICRU Report 62. 1999."},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0014","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2011.05.073","article-title":"Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting","volume":"100","author":"Weber","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/0284186X.2017.1279750","article-title":"Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: On behalf of the Radiotherapy Committee of the EORTC lymphoma group","volume":"56","author":"Aznar","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00066-016-1036-2","article-title":"Quality control of involved field radiotherapy in the HD 13 and HD 14 trials: Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG)","volume":"193","author":"Kriz","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijrobp.2013.03.036","article-title":"Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review","volume":"87","author":"Fairchild","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0360-3016(96)00333-1","article-title":"Randomized trial with early-stage Hodgkin's disease testing 30 Gy versus. 40 Gy extended field radiotherapy alone","volume":"36","author":"D\u00fchmke","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0019","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2003.08.033","article-title":"Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group","volume":"58","author":"Eich","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2011.12.080","article-title":"Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials: Report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance","volume":"83","author":"Bekelman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/acm2.12384","article-title":"Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials","volume":"19","author":"Moran","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2023.05.011_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0360-3016(84)90460-7","article-title":"Radiotherapy quality assurance in clinical trials","volume":"10","author":"Perez","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djt031","article-title":"Quality assurance for radiotherapy: A priority for clinical trials","volume":"105","author":"Goodman","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0024","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2014.08.348","article-title":"Global harmonization of quality assurance naming conventions in radiation therapy clinical trials","volume":"90","author":"Melidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1053-4296(97)80043-4","article-title":"Patterns of care studies: Past, present, and future","volume":"7","author":"Hanks","year":"1997","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2021.11.018","article-title":"The radiotherapy quality assurance gap among phase III cancer clinical trials","volume":"166","author":"Corrigan","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.04.012","article-title":"Impact of deviations in target volume delineation: Time for a new RTQA approach?","volume":"137","author":"Cox","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.05.038","article-title":"Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines","volume":"150","author":"Mir","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0029","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00066-016-1048-y","article-title":"New quality assurance program integrating \"modern radiotherapy\" within the German Hodgkin Study Group","volume":"193","author":"Kriz","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.05.011_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623004558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623004558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:08:04Z","timestamp":1759745284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623004558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0360301623004558"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.011","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer\/Lymphoma Study Association\/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}